Monte Rosa Therapeutics Inc (GLUE)
8.48
-0.15
(-1.74%)
USD |
NASDAQ |
Nov 14, 16:00
8.48
0.00 (0.00%)
After-Hours: 05:23
Monte Rosa Therapeutics Total Liabilities (Quarterly): 119.44M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 119.44M |
| March 31, 2024 | 114.23M |
| December 31, 2023 | 124.50M |
| September 30, 2023 | 67.58M |
| June 30, 2023 | 64.96M |
| March 31, 2023 | 65.30M |
| December 31, 2022 | 70.98M |
| September 30, 2022 | 66.51M |
| Date | Value |
|---|---|
| June 30, 2022 | 63.01M |
| March 31, 2022 | 20.13M |
| December 31, 2021 | 18.81M |
| September 30, 2021 | 14.74M |
| June 30, 2021 | 12.26M |
| March 31, 2021 | 241.22M |
| December 31, 2020 | 98.11M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
12.26M
Minimum
Jun 2021
241.22M
Maximum
Mar 2021
77.45M
Average
66.51M
Median
Sep 2022
Total Liabilities (Quarterly) Benchmarks
| Novartis AG | 60.08B |
| MEI Pharma Inc | 8.355M |
| Evoke Pharma Inc | 9.766M |
| Revance Therapeutics Inc | 624.59M |
| Vera Therapeutics Inc | 79.50M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 344.11M |
| Shareholders Equity (Quarterly) | 224.67M |
| Current Ratio | 6.562 |